Cancer drug developer Xynomic Pharma scores funding

Dover, Delaware and Shanghai-based Xynomic Pharma, a cancer drug developer, has raised an undisclosed amount of financing. Northern Light Venture Capital, Zhongshan Bison Healthcare Investment Limited and Hakim Unique Internet Company Limited led the round with participation from other investors that included Prosperico Ventures.

Source: Press Release